Opportunistic Respiratory Infections in HIV Patients Attending Sukraraj Tropical and Infectious Diseases Hospital in Kathmandu, Nepal

References

• UNAIDS. Global HIV & AIDS statistics-2019 fact sheet; 2019 Available from https://www.unaids.org/en/resources/fact-sheet. Accessed 720, 2019.
   Google Scholar
• Pendse R, Gupta S, Yu D, Sarkar S. HIV/AIDS in the South-East Asia region: progress and challenges. J Virus Erad. 2016;2:1–6.
   PubMed Web of Science ®Google Scholar
• National Center for AIDS & STD Control (NCASC), Nepal. Fact sheet 1: HIV epidimic update of Nepal; 2018 Available from http://www.ncasc.gov.np/WAD2018/FACTSHEET-2018-FINAL/Factsheet-2018-final.pdf. Accessed 720, 2019.
   Google Scholar
• Limper AH. The changing spectrum of fungal infections in pulmonary and critical care practice: clinical approach to diagnosis. Proc Am Thorac Soc. 2010;7:163–168. doi:10.1513/pats.200906-049AL20463243
   PubMedGoogle Scholar
• Koziel H, Eichbaum Q, Kruskal BA, et al. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. J Clin Invest. 1998;102:1332–1344. doi:10.1172/JCI5609769325
   PubMed Web of Science ®Google Scholar
• Geraix J, Carvalhaes MABL, Pereira PCM. Different nutritional-state indicators of HIV-positive individuals undergoing antiretroviral therapy. J Venom Anim Toxins Incl Trop Dis. 2008;14:340. doi:10.1590/S1678-91992008000200011
   Web of Science ®Google Scholar
• USA, Department of Health and Human services. United States of America. HIV and opportunistic infection, coinfection and conditions; 2018 Available from https://aidsinfo.nih.gov/understanding-hiv-aids/fact-sheets/26/86/what-is-anopportunistic-infection. Accessed 615, 2018.
   Google Scholar
• Mayaud C, Parrot A, Cadranel J. Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients. Eur Respir J Suppl. 2002;36:28–39. doi:10.1183/09031936.02.00400602
   PubMedGoogle Scholar
• Silva R, Teixeira P, Moreira D. Induced sputum for the diagnosis of lung disease in HIV-positive patients. J Bras Pneumol. 2004;30:452–458. doi:10.1590/S1806-37132004000500009
   Google Scholar
• Walker PA, White DA. Pulmonary disease. Med Clin North Am. 1996;80:1337–1362. doi:10.1016/S0025-7125(05)70493-48941226
   PubMed Web of Science ®Google Scholar
• Ojha CR, Rijal N, Khagendra KC, et al. Lower respiratory tract infections among HIV positive and control group in Nepal. Virus Dis. 2015;26:77–81. doi:10.1007/s13337-015-0254-z
   Google Scholar
• PA MA K, Fatima N, Shameem M. Profile of fungal lower respiratory tract infections and CD4 counts in HIV positive patients. Virol Mycol. 2013;2:113.
   Google Scholar
• Ratnam M, Nayyar AS, Reddy DS, Ruparani B, Chalapathi KV, Azmi SM. CD4 cell counts and oral manifestations in HIV infected and AIDS patients. J Oral Maxillofac Pathol. 2018;22:282. doi:10.4103/jomfp.JOMFP_191_17
   PubMedGoogle Scholar
• Ying R, Granich RM, Gupta S, Willams BG. CD4 cell count: declining value for antiretrovial therapy eligibility. Clin Infect Dis. 2016;62(8):1022–1028. doi:10.1093/cid/civ122426826372
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Laboratory manual for diagnosis of fungal opportunistic infection in HIV/AIDS patients; 2009 Available from https://apps.who.int/iris/handle/10665/205404. Accessed 621, 2019.
   Google Scholar
• Adhikari NA, Rai SK, Singh A, Dahal S, Ghimire G. Intestinal parasitic infections among HIV seropositive and high risk group subjects for HIV infection in Nepal. Nepal Med Coll J. 2006;8:166–170.17203822
   PubMedGoogle Scholar
• Sherchan JB, Ohara H, Sakurada S, et al. Enteric opportunistic parasitics infections among HIV seropositive patients in Kathmandu, Nepal. Kathmandu Univ Med J (KUMJ). 2012;11(2):15–17.
   Google Scholar
• Ghimire A, Bhandari S, Tandukar S, Amatya J, Bhandari D, Sherchand JB. Enteric parasitic infection among HIV-infected patients visiting Tribhuvan University Teaching Hospital, Nepal. BMC Res Notes. 2016;9:204. doi:10.1186/s13104-016-1938-127048153
   PubMedGoogle Scholar
• Sharma S, Dungana G, Pokharel BM, Rijal BP. Opportunistic infections in relation to CD4 level among HIV seropositive patients from Central Nepal. Nepal Med Coll J. 2010;12(1):1–4.20677600
   PubMedGoogle Scholar
• Dhungel BA, Dhungel KU, Easow JM, Singh YI. Opportunistic infection among HIV seropositive cases in Manipal Teaching Hospital, Pokhara, Nepal. Kathmandu Univ Med J (KUMJ). 2008;6:335–339. doi:10.3126/kumj.v6i3.170820071815
   PubMedGoogle Scholar
• National Center for AIDS & STD Control. National Consolidated Guidelines for Treating and Preventing HIV in Nepal. Goverenment of Nepal. Kathmandu, Nepal: Ministry of Health& Population; 2014.
   Google Scholar
• Cheesbrough M. District Laboratory Practice in Tropical Countries Part II. Cambridge University Press; 2006.
   Google Scholar
• Forbes BASD, Weissfeld AS. Bailey and Scott’s Diagnostic Microbiology. Vol. 11 St. Louis: Mosby; 2002.
   Google Scholar
• Clinical and Laboratory Standards Institute. CLSI Document M100-S25. Performance Standards for Antimicrobial Susceptibility Testing: Twenty Fifth Informational Supplement Ed. Wayne: CLSI; 2015.
   Google Scholar
• Chandwani J, Vyas N, Hooja S, Sharma B, Maheshwari R. Mycological profile of sputum of HIV positive patients with lower respiratory tract infection and its correlation with CD4+ T lymphocyte count. J Clin Diagn Res. 2016;10:28–31.
   Google Scholar
• Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary complications of HIV Infection Study Group. N Engl J Med. 1995;333:845–851. doi:10.1056/NEJM1995092833313057651475
   PubMed Web of Science ®Google Scholar
• Shailaja VV, Pai LA, Mathur DR, Lakshmi V. Prevalence of bacterial and fungal agents causing lower respiratory tract infections in patients with human immunodeficiency virus infection. Indian J Med Microbiol. 2004;22:28–33.17642682
   PubMedGoogle Scholar
• Ogba OM, Abia-Bassey LN, Epoke J. The relationship between opportunistic pulmonary fungal infections and CD4 count levels among HIV-seropositive patients in Calabar, Nigeria. Trans R Soc Trop Med Hyg. 2013;107:170–175. doi:10.1093/trstmh/trs02523288203
   PubMed Web of Science ®Google Scholar
• Jha BJ, Dey S, Tamang MD, Joshy ME, Shivananda PG, Brahmadatan KN. Characterization of Candida species isolated from cases of lower respiratory tract infection. Kathmandu Univ Med J (KUMJ). 2006;4:290–294.18603921
   PubMedGoogle Scholar
• Lin SH, Kuo PH, Hsueh PR, Yang PC, SH K. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa. Respirol. 2007;12:81–87. doi:10.1111/j.1440-1843.2006.00999.x
   PubMed Web of Science ®Google Scholar
• Salami AK, Olatunji PO, Oluboyo PO, Akanbi AA, 2nd, Fawibe, EA Bacterial pneumonia in the AIDS patients. West Af J Med. 2006;25:1–5.
   Google Scholar
• Aggarwal A, Arora U, Bajaj R, Kumari K. Clinico-microbiological study in HIV seropositive patients. J Indian Acad Clin Med. 2005;6:142–145.
   Google Scholar
• Usman AD, Uba A. A survey of bacterial and fungal oppertunistic infection among HIV clients in Kano metropolis. Bajopas. 2011;4(1):148–152.
   Google Scholar
• Sogaard OS, Lohse N, Gerstoft J, et al. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study. Clin Infect Dis. 2008;47:1345–1353. doi:10.1086/59571218834317
   PubMed Web of Science ®Google Scholar
• Ochiabuto MTB, Nwankwo A, Enweani IB, et al. Fungal isolation in HIV patients and CD4 count. International STD Res Rev. 2014;2(2):101–112. doi:10.9734/ISRR/2014/10408
   Google Scholar
• EU EI U, Oshim IO, Okeke-Nwolisa BC, John GU. Microbiological profile of respiratory tract infections among HIV sero-positive subjects attending Nnamdi Azikiwe University Teaching Hospital Nnewi, Nigeria. Am J Med and Med Sci. 2018;8:37–42.
   Google Scholar
• Rimland D, Navin TR, Lennox JL, et al. Prospective study of etiologic agents of community-acquired pneumonia in patients with HIV infection. AIDS. 2002;16:85–95. doi:10.1097/00002030-200201040-0001111741166
   PubMed Web of Science ®Google Scholar
• Mardh PA, Novikova N, Stukalova E. Colonisation of extragenital sites by Candida in women with recurrent vulvovaginal candidosis. BJOG. 2003;110:934–937. doi:10.1111/j.1471-0528.2003.01445.x14550364
   PubMed Web of Science ®Google Scholar
• Peter YJ, Isa AH, Anzaku AS, Builders MI. Pulmonary candidiasis and CD4 count in HIV positive patients seen in Jos, north central Nigeria. Afr J Cln Exper Microbio. 2016;17:46–52. doi:10.4314/ajcem.v17i1.6
   Google Scholar
• Ojo-Bolo O, Oluyege AO. Antibiotics resistance of bacteria associated with pneumonia in HIV/AIDS patients in Nigeria. Am J Infect Dis Microbiol. 2014;2:138–144.
   Google Scholar
• Adeleye A, Uju L, Idika N, Sobande O. Cotrimoxazole resistance in Streptococcus pneumoniae isolated from sputum of HIV-positive patients. West Indian Med J. 2008;57:497–499.19565983
   PubMed Web of Science ®Google Scholar
• Raut S, Gokhale S, Adhikari B. Prevalence of extended spectrum beta-lactamases among E. coli and Klebsiella spp isolates in Manipal, Teaching Hospital, Pokhara, Nepal. JMID. 2015;5(2):69–75. doi:10.5799/ahinjs.02.2015.02.0179
   Google Scholar
• Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933–951. doi:10.1128/CMR.14.4.933-951.200111585791
   PubMed Web of Science ®Google Scholar
• Moges F, Eshetie S, Abebe W, et al. High prevalence of extended-spectrum beta-lactamase-producing gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Amhara region. PLoS One. 2019;14:e0215177. doi:10.1371/journal.pone.021517730986262
   PubMed Web of Science ®Google Scholar
• Pokharel S, Raut S, Adhikari B. Tackling antimicrobial resistance in low-income and middle-income countries. BMJ Global Health. 2019;4(6):e002104. doi:10.1136/bmjgh-2019-002104
   PubMed Web of Science ®Google Scholar